RIZATRIPTAN ACTAVIS rizatriptan (as benzoate) 10mg orodispersible tablet blister pack

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

active_ingredient:

rizatriptan benzoate, Quantity: 14.53 mg (Equivalent: rizatriptan, Qty 10 mg)

MAH:

Medis Pharma Pty Ltd

INN:

rizatriptan benzoate

pharmaceutical_form:

Tablet, orally disintegrating

composition:

Excipient Ingredients: magnesium stearate; mannitol; calcium silicate; crospovidone; colloidal anhydrous silica; aspartame; microcrystalline cellulose; Flavour

administration_route:

Oral

units_in_package:

3, 2, 6

prescription_type:

(S4) Prescription Only Medicine

therapeutic_indication:

RIZATRIPTAN ACTAVIS is indicated for the acute treatment of migraine attacks with or without aura.

leaflet_short:

Visual Identification: White, round, flat, bevel-edged tablet embossed with "IZ 10" on one side and plain on the other side; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

authorization_status:

Licence status A

authorization_date:

2015-02-19